• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂多糖激活的 B 淋巴细胞对产生针对自身和同种异体 MHC I 类抗原的抗体存在选择性无能。

Selective inability of LPS-activated B lymphocytes to produce antibodies against autologous and allogeneic MHC class I antigens.

作者信息

Jiang Y, Möller G

机构信息

Department of Immunology, Stockholm University, Sweden.

出版信息

Cell Immunol. 1994 May;155(2):394-401. doi: 10.1006/cimm.1994.1132.

DOI:10.1006/cimm.1994.1132
PMID:8181073
Abstract

Lipopolysaccharide (LPS)-activated B lymphocytes have been found to produce autoantibodies of a variety of specificities. We found that LPS-induced autoantibodies did not include antibodies against self H-2 class I antigens, suggesting a selective tolerance induction against some, but not other, autoantigens. However, LPS-activated B lymphocytes not only failed to produce antibodies against autologous H-2 class I antigens, but also against allogeneic H-2 class I antigens, suggesting a selective regulation of B cells to synthesize antibodies directed against autologous and allogeneic major histocompatibility complex antigens.

摘要

已发现脂多糖(LPS)激活的B淋巴细胞可产生多种特异性的自身抗体。我们发现,LPS诱导产生的自身抗体不包括针对自身H-2 I类抗原的抗体,这表明对某些自身抗原而非其他自身抗原存在选择性耐受诱导。然而,LPS激活的B淋巴细胞不仅未能产生针对自体H-2 I类抗原的抗体,也未能产生针对同种异体H-2 I类抗原的抗体,这表明对B细胞存在选择性调节,使其合成针对自体和同种异体主要组织相容性复合体抗原的抗体。

相似文献

1
Selective inability of LPS-activated B lymphocytes to produce antibodies against autologous and allogeneic MHC class I antigens.脂多糖激活的 B 淋巴细胞对产生针对自身和同种异体 MHC I 类抗原的抗体存在选择性无能。
Cell Immunol. 1994 May;155(2):394-401. doi: 10.1006/cimm.1994.1132.
2
[Humoral autoimmune reactions directed against autoantigens of the H-2 histocompatibility system in mice with developing Rauscher leukemia].[在患劳斯氏白血病的小鼠中针对H-2组织相容性系统自身抗原的体液自身免疫反应]
Eksp Onkol. 1988;10(6):21-5.
3
Autoantibodies to ribosomal P antigens with immune complex glomerulonephritis in SJL mice treated with pristane.在用 pristane 处理的 SJL 小鼠中,针对核糖体 P 抗原的自身抗体与免疫复合物肾小球肾炎相关。
J Immunol. 1996 Oct 1;157(7):3200-6.
4
B cell receptor-independent stimuli trigger immunoglobulin (Ig) class switch recombination and production of IgG autoantibodies by anergic self-reactive B cells.不依赖B细胞受体的刺激可触发免疫球蛋白(Ig)类别转换重组,并由无反应性自身反应性B细胞产生IgG自身抗体。
J Exp Med. 2003 Apr 7;197(7):845-60. doi: 10.1084/jem.20022144. Epub 2003 Mar 31.
5
Rapid induction of autoantibodies by endogenous ovarian antigens and activated T cells: implication in autoimmune disease pathogenesis and B cell tolerance.内源性卵巢抗原和活化T细胞快速诱导自身抗体:对自身免疫性疾病发病机制和B细胞耐受性的影响
J Immunol. 1996 May 1;156(9):3535-40.
6
Xenotransplantation and ABO incompatible transplantation: the similarities they share.异种移植与ABO血型不相容移植:它们的相似之处。
Transfus Apher Sci. 2006 Aug;35(1):45-58. doi: 10.1016/j.transci.2006.05.007. Epub 2006 Aug 14.
7
Dual MHC class I and class II restriction of a single T cell receptor: distinct modes of tolerance induction by two classes of autoantigens.单个T细胞受体的双MHC I类和II类限制:两类自身抗原诱导耐受的不同模式。
J Immunol. 1999 Feb 15;162(4):2008-15.
8
A model of peptide-induced lupus autoimmune B cell epitope spreading is strain specific and is not H-2 restricted in mice.肽诱导的狼疮自身免疫性B细胞表位扩展模型具有品系特异性,在小鼠中不受H-2限制。
J Immunol. 1998 Jan 1;160(1):502-8.
9
Cross-linking of MHC class II molecules interferes with phorbol 12,13-dibutyrate-induced differentiation of resting B cells by inhibiting Rac-associated ROS-dependent ERK/p38 MAP kinase pathways leading to NF-kappaB activation.MHC II类分子的交联通过抑制与Rac相关的活性氧依赖性ERK/p38丝裂原活化蛋白激酶途径,干扰佛波醇12,13 -二丁酸酯诱导的静息B细胞分化,该途径会导致核因子κB活化。
Mol Immunol. 2007 Mar;44(7):1577-86. doi: 10.1016/j.molimm.2006.08.017. Epub 2006 Oct 2.
10
Tolerance induction using autologous bone marrow modified with an allogeneic class I MHC gene.
Transplant Proc. 1993 Feb;25(1 Pt 1):348-9.